Q1 2025
Read transcript →KalVista Pharmaceuticals, Inc. (KALV) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$19.19
+0.16%
Mkt Cap $977.33M
All KALV earnings call transcripts, listed in reverse chronological order. Earnings Labs publishes the complete transcript of every KALV earnings call — free, no signup, with AI-generated summaries and key takeaways.
Q3 2025
Read transcript →Q1 2026
Read transcript →